AI in pharma has the potential to overhaul drug discovery, clinical trials, manufacturing, and marketing by analysing vast datasets to speed up processes, reduce costs, and enable personalised ...

META’s AI monetization is driving 24% YoY revenue growth and stronger earnings. Click for more on META and MSFT.

If AI can already hold our attention this well -- this early -- what happens when it gets better?This is why the Kannywood conversation is timely. With NITDA announcing a partnership with the Future ...

It claims that its students learn twice as fast and score in the top 1% to 2% on MAP testing, a nationwide measure of growth ...

What if Watertown had its own AI Lab?That wasn’t the topic of Executive Business Consultant Jonathan Sheeley’s January 29 presentation to a group of over 40 local business ...

AI drives changes in SA IT skills needsThe widespread adoption of artificial intelligence is driving rapid change in the IT job market and the skills needed within the IT space.Issued by ...

The online encyclopedia is an antidote to an increasingly poisoned information ecosystem. Researchers should help to nourish ...

Built-in IDE: Code directly in the browser without needing to set up a local environment.

This article is the first of a three-part series on artificial intelligence and the changing nature of evidence in New York ...

Every synthetic dataset generated today trains tomorrow's models while potentially poisoning the ecosystem those models ...

Meta is testing premium subscriptions for Instagram, Facebook, and WhatsApp. Pricing and launch markets aren’t public yet, ...